Aramburu, J., Rao, A., & Klee, C. B. (2000). Calcineurin: From structure to function. Current Topics in Cellular Regulation, 36, 237–295. https://doi.org/10.1016/s0070-2137(01)80011-x
Bhatnagar, D., Soran, H., & Durrington, P. N. (2008). Hypercholesterolaemia and its management. BMJ (Clinical Research Ed.), 337, a993. https://doi.org/10.1136/bmj.a993
Bkaily, G., Jaalouk, D., Sader, S., Shbaklo, H., Pothier, P., Jacques, D., D’Orléans-Juste, P., Cragoe, E. J., & Bose, R. (1998). Taurine indirectly increases [Ca]i by inducing Ca2+ influx through the Na(+)-Ca2+ exchanger. Molecular and Cellular Biochemistry, 188(1–2), 187–197.
Chang, Y.-Y., Chou, C.-H., Chiu, C.-H., Yang, K.-T., Lin, Y.-L., Weng, W.-L., & Chen, Y.-C. (2011). Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. Journal of Agricultural and Food Chemistry, 59(1), 450–457. https://doi.org/10.1021/jf103167u
Chen, W., Guo, J.-X., & Chang, P. (2012). The effect of taurine on cholesterol metabolism. Molecular Nutrition & Food Research, 56(5), 681–690. https://doi.org/10.1002/mnfr.201100799
Chen, W., Suruga, K., Nishimura, N., Gouda, T., Lam, V. N., & Yokogoshi, H. (2005). Comparative regulation of major enzymes in the bile acid biosynthesis pathway by cholesterol, cholate and taurine in mice and rats. Life Sciences, 77(7), 746–757. https://doi.org/10.1016/j.lfs.2004.11.036
Chiang, J. Y. L. (2009). Bile acids: Regulation of synthesis. Journal of Lipid Research, 50(10), 1955–1966. https://doi.org/10.1194/jlr.R900010-JLR200
Chiang, J. Y. L. (2013). Bile acid metabolism and signaling. Comprehensive Physiology, 3(3), 1191–1212. https://doi.org/10.1002/cphy.c120023
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., Maloney, P. R., Willson, T. M., & Kliewer, S. A. (2000). A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Molecular Cell, 6(3), 517–526. https://doi.org/10.1016/s1097-2765(00)00051-4
Guo, J., Gao, Y., Cao, X., Zhang, J., & Chen, W. (2017). Cholesterol-lowing effect of taurine in HepG2 cell. Lipids in Health and Disease, 16(1), 56. https://doi.org/10.1186/s12944-017-0444-3
Ko, Y., Chang, H., & Lee, D. (2017). Analysis of Taurine’s Anti-Down Syndrome Potential in Caenorhabditis elegans—PubMed. https://pubmed.ncbi.nlm.nih.gov/28849527/
Kockx, M., Jessup, W., & Kritharides, L. (2010). Cyclosporin A and atherosclerosis—Cellular pathways in atherogenesis. Pharmacology & Therapeutics, 128(1), 106–118. https://doi.org/10.1016/j.pharmthera.2010.06.001
Lam, N. V., Chen, W., Suruga, K., Nishimura, N., Goda, T., & Yokogoshi, H. (2006). Enhancing effect of taurine on CYP7A1 mRNA expression in Hep G2 cells. Amino Acids, 30(1), 43–48. https://doi.org/10.1007/s00726-005-0244-3
Lambert, I. H., Kristensen, D. M., Holm, J. B., & Mortensen, O. H. (2015). Physiological role of taurine—From organism to organelle. Acta Physiologica (Oxford, England), 213(1), 191–212. https://doi.org/10.1111/apha.12365
Li, T., Jahan, A., & Chiang, J. Y. L. (2006). Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology (Baltimore, Md.), 43(6), 1202–1210. https://doi.org/10.1002/hep.21183
Liang, Q., Bueno, O. F., Wilkins, B. J., Kuan, C.-Y., Xia, Y., & Molkentin, J. D. (2003). C-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. The EMBO Journal, 22(19), 5079–5089. https://doi.org/10.1093/emboj/cdg474
Mannu, G. S., Zaman, M. J. S., Gupta, A., Rehman, H. U., & Myint, P. K. (2013). Evidence of lifestyle modification in the management of hypercholesterolemia. Current Cardiology Reviews, 9(1), 2–14. https://doi.org/10.2174/157340313805076313
Miyazaki, T., Honda, A., Ikegami, T., & Matsuzaki, Y. (2013). The role of taurine on skeletal muscle cell differentiation. Advances in Experimental Medicine and Biology, 776, 321–328. https://doi.org/10.1007/978-1-4614-6093-0_29
Mochizuki, H., Takido, J., & Yokogoshi, H. (1999). Improved suppression by dietary taurine of the fecal excretion of bile acids from hypothyroid rats. Bioscience, Biotechnology, and Biochemistry, 63(4), 753–755. https://doi.org/10.1271/bbb.63.753
Muili, K. A., Wang, D., Orabi, A. I., Sarwar, S., Luo, Y., Javed, T. A., Eisses, J. F., Mahmood, S. M., Jin, S., Singh, V. P., Ananthanaravanan, M., Perides, G., Williams, J. A., Molkentin, J. D., & Husain, S. Z. (2013). Bile acids induce pancreatic acinar cell injury and pancreatitis by activating calcineurin. The Journal of Biological Chemistry, 288(1), 570–580. https://doi.org/10.1074/jbc.M112.428896
Murakami, N., Riella, L. V., & Funakoshi, T. (2014). Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: A systematic review and meta-analysis. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 14(10), 2317–2327. https://doi.org/10.1111/ajt.12852
Murakami, S., Fujita, M., Nakamura, M., Sakono, M., Nishizono, S., Sato, M., Imaizumi, K., Mori, M., & Fukuda, N. (2016). Taurine ameliorates cholesterol metabolism by stimulating bile acid production in high-cholesterol-fed rats. Clinical and Experimental Pharmacology & Physiology, 43(3), 372–378. https://doi.org/10.1111/1440-1681.12534
Riella, L. V., Gabardi, S., & Chandraker, A. (2012). Dyslipidemia and its therapeutic challenges in renal transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 12(8), 1975–1982. https://doi.org/10.1111/j.1600-6143.2012.04084.x
Rusnak, F., & Mertz, P. (2000). Calcineurin: Form and function. Physiological Reviews, 80(4), 1483–1521. https://doi.org/10.1152/physrev.2000.80.4.1483
Schaffer, S. W., Jong, C. J., Ramila, K. C., & Azuma, J. (2010). Physiological roles of taurine in heart and muscle. Journal of Biomedical Science, 17 Suppl 1, S2. https://doi.org/10.1186/1423-0127-17-S1-S2
Suk, H. Y., Zhou, C., Yang, T. T. C., Zhu, H., Yu, R. Y. L., Olabisi, O., Yang, X., Brancho, D., Kim, J.-Y., Scherer, P. E., Frank, P. G., Lisanti, M. P., Calvert, J. W., Lefer, D. J., Molkentin, J. D., Ghigo, A., Hirsch, E., Jin, J., & Chow, C.-W. (2013). Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. The Journal of Biological Chemistry, 288(5), 3477–3488. https://doi.org/10.1074/jbc.M112.419150
Vaziri, N. D., Liang, K., & Azad, H. (2000). Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. The Journal of Pharmacology and Experimental Therapeutics, 294(2), 778–783.
Wei, S., Huang, Q., Li, J., Liu, Z., You, H., Chen, Y., & Gong, J. (2012). Taurine attenuates liver injury by downregulating phosphorylated p38 MAPK of Kupffer cells in rats with severe acute pancreatitis. Inflammation, 35(2), 690–701. https://doi.org/10.1007/s10753-011-9362-0